Latest News about VRTX
Recent news which mentions VRTX
2 Biotech Stocks to Buy Hand Over Fist in February
February 09, 2025
From Motley Fool
UnitedHealth, Vertex Pharmaceuticals, Axon Enterprise And A Major Energy Stock: CNBC's 'Final Trades'
February 06, 2025
From Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
February 04, 2025
From Benzinga
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
February 04, 2025
Tickers
VRTX
From Motley Fool
3 Magnificent Stocks to Buy and Hold Forever
February 03, 2025
From Motley Fool
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
February 02, 2025
Tickers
VRTX
From Motley Fool
From Motley Fool
FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief
January 31, 2025
From Benzinga
Vertex Pharmaceuticals Shares Are Up Today: What's Going On?
January 31, 2025
From Benzinga
Charter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday
January 31, 2025
From Benzinga
From Wall Street Pit
This Everest Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
January 30, 2025
From Benzinga
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
January 25, 2025
From Motley Fool
From Motley Fool
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
January 21, 2025
From Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
January 20, 2025
From Benzinga
3 Unstoppable Stocks to Buy in 2025
January 18, 2025
From Motley Fool
HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'
January 16, 2025
From Benzinga
Tickers
VRTX
From Motley Fool
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
January 14, 2025
From Benzinga
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials
January 14, 2025
From Benzinga
Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts
January 14, 2025
From Motley Fool
My 3 Highest-Conviction Growth Stocks to Buy in 2025
January 13, 2025
From Motley Fool
Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure
January 10, 2025
From Benzinga
Vertex Grapples With Bearish Chart As Death Cross Emerges
January 07, 2025
Tickers
VRTX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.